7:00 am Networking

8:00 am Supercharging Fundamental Knowledge & Understanding of CAR-TCR Biology & Immunological Function

• Stanley Frankel Chief Medical Officer, Cytovia
• Tony Ho Industry Expert, Self Employed, Previously CRISPR Therapeutics
• Jens Hasskarl Chief Medical Officer, Tigen Pharma

10:00 am Networking

10:30 am Overcoming Mechanisms of Treatment Resistance of CAR-TCR Engineered T-Cells in Solid Tumors

• Daniel Powell Associate Professor of Pathology & Lab Medicine, University of Pennsylvania
• Eric Von Hofe Senior Advisor, AffyImmune

12:30 pm Lunch

1:30 pm Exploring the Advantages & Applications of CAR-T Technology Beyond Oncology

• Sonja Schrepfer Senior Vice President, Head of Hypoimmune Platforms, Sana Biotechnology
• Miloš Miljković Chief Medical Officer, Cartesian Therapeutics
• Marko Radic Associate Professor of Microbiology, Immunology & Biochemistry , University of Tennessee Health Science Center
• Samik Basu Chief Scientific Officer, Cabaletta Bio

3:30 pm Networking

4:00 pm CAR-TCR Think-Tank

• Luis Borges Chief Scientific Officer, Century Therapeutics
• Helen Tayton-Martin Chief Business Officer, Adaptimmune
• Adrian Bot Chief Scientific Officer & Executive Vice President, Research & Development, Capstan Therapeutics

4:00 pm Investors Roundtable

5:00 pm Diversity in CAR-TCR

• Nushmia Khokhar Chief Medical Officer, Umoja Biopharma
• Sophie Papa Chief Medical Officer, Enara Bio
• Angela Justice Chief People Officer, TCR2
• Brad Hartman Chief People Officer, Be Biopharma

6:30 pm Ambassador Reception hosted by Precision Advance